Establishment and clinical application of flow cytometric immuno-bead array assay in detecting platelet-associate autoantibody against platelate-specific glycoproteins

ZHAO Yun-xiao,HE Yang,ZHU Ming-qing,RUAN Chang-geng
2012-01-01
Abstract:Objective To establish a new method to detect platelet-associate autoantibodies against platelate-specific glycoproteinsss by flow cytometric immuno-bead array assay(FCIBA) and study its clinical application.Methods A series of beads were detected by the flow cytometry.The beads with different fluorescent intensity were used for coating different anti-platelet glycoproteins monoclonal antibodies,anti-GPⅨ(SZ1),anti-GPⅠ b(SZ2),anti-GPⅢ a(SZ21),anti-GPⅡ b(SZ22),anti-P-selectin(SZ51).In addition,its results were compared with monoclonal antibody immobilization of platelet antigens(MAIPA) technology.The new method was used for detecting five autoantibodies SZ1,SZ2,SZ21,SZ22 and SZ51.Results The coefficient of variation(CV) of intra-repetition and inter-repetition were small in difference.ITP group was compared with NITP group and the healthy control,the difference in the MFI was significant(P<0.01).The specificity of FCIBA was 80.2%(70/86),and the specificity of MAIPA was 80.2%(69/86),the difference was not significant(P>0.05).The sensitivity was 62.00%(31/50),which was higher than that of MAIPA 31.00%(19/50),the difference was significant(P<0.05).Conclusion FCIBA can be used to detect platelet-associate autoantibodies,particularly in conjunction with five antibodies can improve the positivity rate,which might be a useful method to improve the diagnosis of ITP.
What problem does this paper attempt to address?